Detalles de la búsqueda
1.
Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics.
Rheumatology (Oxford)
; 63(2): 542-550, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37252826
2.
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Ann Rheum Dis
; 82(6): 773-787, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953263
3.
Does the Type of Failure and the Choice of the Second Biologic Influence Response and Persistence on Medication in Rheumatoid Arthritis?
J Clin Rheumatol
; 29(7): 332-340, 2023 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37644656
4.
Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey.
Rheumatol Int
; 42(9): 1555-1564, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35449236
5.
Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis.
Ann Rheum Dis
; 80(12): 1522-1529, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34215644
6.
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study.
Ann Rheum Dis
; 80(1): 96-102, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32719038
7.
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Ann Rheum Dis
; 80(1): 71-87, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33158881
8.
Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study.
Rheumatol Int
; 41(3): 585-593, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33258003
9.
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
Ann Rheum Dis
; 79(11): 1400-1413, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32759265
10.
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study.
Clin Exp Rheumatol
; 38(5): 848-857, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31858963
11.
Genetics of rheumatoid arthritis contributes to biology and drug discovery.
Nature
; 506(7488): 376-81, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24390342
12.
Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren's syndrome enrolled in a large observational US registry.
Rheumatol Int
; 40(8): 1239-1248, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449040
13.
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
; 391(10139): 2503-2512, 2018 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29908669
14.
Baricitinib in Patients with Refractory Rheumatoid Arthritis.
N Engl J Med
; 374(13): 1243-52, 2016 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27028914
15.
Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies.
Ann Rheum Dis
; 77(7): 988-995, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29463520
16.
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2.
Rheumatology (Oxford)
; 57(11): 2001-2011, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30053162
17.
Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis.
Rheumatology (Oxford)
; 57(5): 900-908, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29415145
18.
Design characteristics of the Corrona Japan rheumatoid arthritis registry.
Mod Rheumatol
; 28(1): 95-100, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28448195
19.
Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'' by Zheng et al.
Ann Rheum Dis
; 81(11): e225, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33177102
20.
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis.
Ann Rheum Dis
; 76(6): 1020-1030, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28213566